Same thing happening

From Wikipedia:

>Prima stockPrima has been publicly traded on the ASX since July 2001. The company did its IPO on Nasdaq in April 2012 and trades on that exchange in the form of ADRs. The current conversion rate between Prima ordinary shares and ADRs is 30:1.[18] On 14 May 2015 Prima BioMed announced a A$15 million investment from Ridgeback Capital Investments, a US-based specialist healthcare investor.[19] On 19 and 20 May 2015, just after Prima announced final Overall Survival data for its CAN-003 study of CVac, the company's ADRs experienced a significant two-day increase on Nasdaq. On 19 May the stock increased from US$0.52 per share from the previous session's close to US$1.60. On 20 May the stock opened at US$2.13 and rising as high as US$6.48 per share before closing at US$5.91. On that day 91.46 million ADRs were traded.


Well, seems all these rights issues etc. is a repeat of what has happened previously. Wonder what the story would be in due time. Seems conveniently the shares always rise right after such capital raising, followed by a HUGE drop.

Once again, I urge caution in trading this stock and minus all those optimism and nonsense 'broker reports/target price'. I have been in the game long enough to know it. Which one of them valued IMM to be 10cents?

I'm just trying to get everyone be rationale here. BioMed is a BIG RISK, and from my own research, it seems that IMM is a company that requires extreme caution.